Edwards Lifesciences Corp (EW)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$85.38
Buy
$85.40
$0.58 (+0.68%)
Prices updated at 19 Dec 2025, 20:21 EST
| Prices minimum 15 mins delay
Prices in USD
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 79.46 |
| 2023 | 80.47 |
| 2022 | 83.79 |
| 2021 | 76.13 |
| 2020 | 75.36 |
| 2019 | 74.37 |
| 2018 | 74.77 |
| 2017 | 74.52 |
| 2016 | 73.09 |
| 2015 | 75.25 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 8.48 |
| 2024 | 7.07 |
| 2023 | 8.02 |
| 2022 | 8.74 |
| 2021 | 16.11 |
| 2020 | 13.18 |
| 2019 | 11.92 |
| 2018 | 9.04 |
| 2017 | 7.37 |
| 2016 | 7.14 |
| 2015 | 7.12 |
Price/Forward earnings (YTD)
29.85
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 37.24 |
| 2023 | 15.89 |
| 2022 | 18.12 |
| 2021 | 19.10 |
| 2020 | 12.00 |
| 2019 | 17.73 |
| 2018 | 13.14 |
| 2017 | 11.47 |
| 2016 | 13.30 |
| 2015 | 13.06 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.31 |
| 2023 | 1.41 |
| 2022 | 1.43 |
| 2021 | 1.46 |
| 2020 | 1.58 |
| 2019 | 1.56 |
| 2018 | 1.70 |
| 2017 | 1.92 |
| 2016 | 1.72 |
| 2015 | 1.62 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.